It would be interesting to investigate if increased levels of EGFL7 can be detected before the onset of clinical manifestations and might represent the ideal angiogenetic factor to distinguish between isolated IUGR and e-PE, for which a prospective larger observational study in low and high-risk pregnancies would be needed. This evidence concerns the gene EGFL7 and fetal growth restriction.